{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:15:48Z","timestamp":1789823748561,"version":"4.0.1"},"reference-count":39,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The oncolytic polio-rhinovirus recombinant (PVSRIPO) has demonstrated promise in currently ongoing phase I\/II clinical trials against recurrent glioblastoma and was granted breakthrough therapy designation by the Food and Drug Administration\/Center for Biologics Evaluation and Research. A reliable clinical assay to document expression of the poliovirus receptor, CD155, in routinely available patient tumor samples is needed for continued clinical development of PVSRIPO oncolytic immunotherapy in primary brain tumors and beyond.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To validate a novel anti-CD155 antibody for immunohistochemistry and develop a robust, reliable, and specific protocol for detecting CD155 expression in glioblastoma formalin-fixed, paraffin-embedded (FFPE) tissue samples. To characterize the expression of CD155 in human glioblastoma cells as well as to evaluate the influence of CD155 expression levels on tumor cell susceptibility to PVSRIPO infection and killing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Immunohistochemical staining on glioblastoma FFPE tissue sections and immunoblot of corresponding frozen tissues were performed. Positive controls were confirmed sites of poliovirus propagation, spinal cord anterior horn, and tonsils; negative controls were vascular smooth muscle in patient samples and FFPE sections from a confirmed CD155-negative Burkitt lymphoma line (Raji).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>We succeeded in developing a reliable assay to specifically detect CD155 by immunohistochemistry in glioblastoma FFPE sections. Our data suggest widespread, virtually universal expression of CD155 in glioblastoma cells at levels commensurate with susceptibility to PVSRIPO infection and killing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Anti-CD155 antibody D3G7H achieves monospecific detection of CD155 in immunoblots of tumor homogenates and immunohistochemistry of tumor FFPE sections. Our assay has utility in defining appropriate use of PVSRIPO in oncolytic immunotherapy against malignant glioma and other cancer histotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2016-0580-oa","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T11:43:55Z","timestamp":1503402235000},"page":"1697-1704","source":"Crossref","is-referenced-by-count":55,"title":["Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas"],"prefix":"10.5858","volume":"141","author":[{"given":"Vidyalakshmi","family":"Chandramohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Keir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Lefaivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Perkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darell D.","family":"Bigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gromeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger E.","family":"McLendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"5","key":"2020081219454485300_i1543-2165-141-12-1697-b01","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"12","key":"2020081219454485300_i1543-2165-141-12-1697-b02","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1073\/pnas.97.12.6803","article-title":"Intergeneric poliovirus recombinants for the treatment of malignant glioma","volume":"97","author":"Gromeier","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"2020081219454485300_i1543-2165-141-12-1697-b03","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1002\/cncr.28862","article-title":"Oncolytic polio virotherapy of cancer","volume":"120","author":"Brown","year":"2014","journal-title":"Cancer"},{"issue":"8","key":"2020081219454485300_i1543-2165-141-12-1697-b04","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2457","article-title":"Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation","volume":"9","author":"Takai","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2020081219454485300_i1543-2165-141-12-1697-b05","article-title":"Universal Protein Resource (UniProt)","author":"European Bioinformatics Institute (EMBL-EBI), SIB Swiss Institute of Bioinformatics, Protein Information Resource (PIR)"},{"issue":"5","key":"2020081219454485300_i1543-2165-141-12-1697-b06","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(89)90690-9","article-title":"Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily","volume":"56","author":"Mendelsohn","year":"1989","journal-title":"Cell"},{"issue":"8","key":"2020081219454485300_i1543-2165-141-12-1697-b07","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.77.8.4827-4835.2003","article-title":"Complexes of poliovirus serotypes with their common cellular receptor, CD155","volume":"77","author":"He","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"2020081219454485300_i1543-2165-141-12-1697-b08","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1002\/j.1460-2075.1990.tb07520.x","article-title":"The poliovirus receptor protein is produced both as membrane-bound and secreted forms","volume":"9","author":"Koike","year":"1990","journal-title":"EMBO J"},{"key":"2020081219454485300_i1543-2165-141-12-1697-b09","first-page":"101","article-title":"Poliovirus receptors","author":"Wimmer","year":"1993","journal-title":"Cellular Receptors for Animal Viruses"},{"issue":"1","key":"2020081219454485300_i1543-2165-141-12-1697-b10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1073\/pnas.97.1.73","article-title":"Three-dimensional structure of poliovirus receptor bound to poliovirus","volume":"97","author":"Belnap","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2020081219454485300_i1543-2165-141-12-1697-b11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/viro.1994.1493","article-title":"The poliovirus receptor: identification of domains and amino acid residues critical for virus binding","volume":"203","author":"Bernhardt","year":"1994","journal-title":"Virology"},{"issue":"1","key":"2020081219454485300_i1543-2165-141-12-1697-b12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1073\/pnas.97.1.79","article-title":"Interaction of the poliovirus receptor with poliovirus","volume":"97","author":"He","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3159","key":"2020081219454485300_i1543-2165-141-12-1697-b13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.122.3159.105","article-title":"Emerging concept of poliomyelitis infection","volume":"122","author":"Bodian","year":"1955","journal-title":"Science"},{"issue":"3209","key":"2020081219454485300_i1543-2165-141-12-1697-b14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis; reappraisal in the light of new data","volume":"123","author":"Sabin","year":"1956","journal-title":"Science"},{"issue":"5","key":"2020081219454485300_i1543-2165-141-12-1697-b15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/342682","article-title":"Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection","volume":"186","author":"Iwasaki","year":"2002","journal-title":"J Infect Dis"},{"issue":"3873","key":"2020081219454485300_i1543-2165-141-12-1697-b16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.163.3873.1336","article-title":"Poliovirus crystals within the endoplasmic reticulum of endothelial and mononuclear cells in the monkey spinal cord","volume":"163","author":"Blinzinger","year":"1969","journal-title":"Science"},{"issue":"2","key":"2020081219454485300_i1543-2165-141-12-1697-b17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/viro.1993.1433","article-title":"Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication","volume":"195","author":"Freistadt","year":"1993","journal-title":"Virology"},{"issue":"14","key":"2020081219454485300_i1543-2165-141-12-1697-b18","first-page":"1","article-title":"Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery","volume":"52","author":"Carlson","year":"2011","journal-title":"Curr Protoc Pharmacol"},{"issue":"pt 12","key":"2020081219454485300_i1543-2165-141-12-1697-b19","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1099\/0022-1317-66-12-2563","article-title":"Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site","volume":"66","author":"Nobis","year":"1985","journal-title":"J Gen Virol"},{"issue":"3","key":"2020081219454485300_i1543-2165-141-12-1697-b20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1215\/S1152851703000577","article-title":"Poliovirus receptor CD155-targeted oncolysis of glioma","volume":"6","author":"Merrill","year":"2004","journal-title":"Neuro Oncol"},{"issue":"1","key":"2020081219454485300_i1543-2165-141-12-1697-b21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020081219454485300_i1543-2165-141-12-1697-b22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/MCB.01441-12","article-title":"Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G","volume":"33","author":"Dobrikov","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"22","key":"2020081219454485300_i1543-2165-141-12-1697-b23","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1128\/JVI.01883-14","article-title":"Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine\/arginine-rich protein kinase","volume":"88","author":"Brown","year":"2014","journal-title":"J Virol"},{"issue":"18","key":"2020081219454485300_i1543-2165-141-12-1697-b24","first-page":"4130","article-title":"Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII","volume":"57","author":"Wikstrand","year":"1997","journal-title":"Cancer Res"},{"issue":"11","key":"2020081219454485300_i1543-2165-141-12-1697-b25","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1128\/MCB.10.11.5700","article-title":"Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues","volume":"10","author":"Freistadt","year":"1990","journal-title":"Mol Cell Biol"},{"issue":"9","key":"2020081219454485300_i1543-2165-141-12-1697-b26","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1074\/jbc.272.9.5579","article-title":"The promoters for human and monkey poliovirus receptors: requirements for basic and cell type-specific activity","volume":"272","author":"Solecki","year":"1997","journal-title":"J Biol Chem"},{"issue":"3","key":"2020081219454485300_i1543-2165-141-12-1697-b27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0092-1157(78)80010-9","article-title":"International comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine","volume":"6","author":"Boulger","year":"1978","journal-title":"J Biol Stand"},{"issue":"10","key":"2020081219454485300_i1543-2165-141-12-1697-b28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20032206","article-title":"DNAM-1 and PVR regulate monocyte migration through endothelial junctions","volume":"199","author":"Reymond","year":"2004","journal-title":"J Exp Med"},{"issue":"8","key":"2020081219454485300_i1543-2165-141-12-1697-b29","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","article-title":"Prostate cancer in a transgenic mouse","volume":"92","author":"Greenberg","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5369","key":"2020081219454485300_i1543-2165-141-12-1697-b30","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1126\/science.280.5369.1618","article-title":"Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor","volume":"280","author":"Geraghty","year":"1998","journal-title":"Science"},{"issue":"4","key":"2020081219454485300_i1543-2165-141-12-1697-b31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","article-title":"Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule","volume":"198","author":"Bottino","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"2020081219454485300_i1543-2165-141-12-1697-b32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2020081219454485300_i1543-2165-141-12-1697-b33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.21021","article-title":"Tightly regulated induction of the adhesion molecule necl-5\/CD155 during rat liver regeneration and acute liver injury","volume":"43","author":"Erickson","year":"2006","journal-title":"Hepatology"},{"issue":"15","key":"2020081219454485300_i1543-2165-141-12-1697-b34","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","article-title":"ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype","volume":"113","author":"Soriani","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2020081219454485300_i1543-2165-141-12-1697-b35","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.0901226","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells","volume":"183","author":"Carlsten","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"2020081219454485300_i1543-2165-141-12-1697-b36","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.0802845","article-title":"NK cells recognize and kill human glioblastoma cells with stem cell-like properties","volume":"182","author":"Castriconi","year":"2009","journal-title":"J Immunol"},{"issue":"8","key":"2020081219454485300_i1543-2165-141-12-1697-b37","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1128\/JVI.05788-11","article-title":"The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR","volume":"86","author":"Matusali","year":"2012","journal-title":"J Virol"},{"issue":"2","key":"2020081219454485300_i1543-2165-141-12-1697-b38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ni1156","article-title":"Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141","volume":"6","author":"Tomasec","year":"2005","journal-title":"Nat Immunol"},{"issue":"9","key":"2020081219454485300_i1543-2165-141-12-1697-b39","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00262-009-0682-y","article-title":"Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines","volume":"58","author":"Casado","year":"2009","journal-title":"Cancer Immunol Immunother"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/12\/1697\/1446353\/arpa_2016-0580-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/12\/1697\/1446353\/arpa_2016-0580-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:38:26Z","timestamp":1764790706000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/141\/12\/article-p1697.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2016-0580-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}